日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Evaluating the association of antibiotic spectrum and treatment responses of cystic fibrosis pulmonary exacerbations

评估抗生素谱与囊性纤维化肺部急性加重治疗反应之间的关联

Somayaji, Ranjani; Cogen, Jonathan D; VanDevanter, Donald; LiPuma, John J; West, Natalie E; Sanders, Don B; Gerber, Jeffrey S; Kronman, Matthew P; Goss, Christopher H; Flume, Patrick A; Heltshe, Sonya L

Impact of elexacaftor/tezacaftor/ivacaftor on gastrointestinal outcomes, inflammation, exocrine pancreatic function and fat malabsorption: Report of PROMISE pediatric substudy

依来卡托/替扎卡托/伊伐卡托对胃肠道结局、炎症、外分泌胰腺功能和脂肪吸收不良的影响:PROMISE儿科子研究报告

Green, Nicole; Vu, Phuong; Xie, Jing; Schwarzenberg, Sarah Jane; Freedman, Steven; Narkewicz, Michael; Pittman, Jessica; Ratjen, Felix; Rosenfeld, Margaret; Pope, Christopher; Duong, Jennifer; Hoffman, Lucas; Heltshe, Sonya; Lusman, Sarah S

Correlates of FEV₁ deficit in pulmonary exacerbations of cystic fibrosis and associated clinical outcomes

囊性纤维化肺部急性加重期FEV₁不足的相关因素及相关临床结局

McElvaney, Oliver J; Heltshe, Sonya L; Sanders, Don B; West, Natalie E; Fogarty, Barbra; VanDevanter, Donald R; Flume, Patrick A; Goss, Christopher H

Long-term reductions in inflammation in people with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor

使用 elexacaftor/tezacaftor/ivacaftor 治疗囊性纤维化患者可长期降低炎症水平

Sagel, Scott D; Poore, T Spencer; Wagner, Brandie D; Xie, Jing; Heltshe, Sonya L; Cross, Mary; Bratcher, Preston E; Taylor-Cousar, Jennifer L; Wilson, Alexandra; McBennett, Kimberly; Morgan, Sarah J; Singh, Pradeep K; Nichols, David P; Kelly, Andrea; Solomon, George M

Risk Factors for Longitudinal eGFR Decline in Adults with Cystic Fibrosis

囊性纤维化成人患者纵向eGFR下降的风险因素

Nacharaju, Deepthi; Zelnick, Leila R; Ramos, Kathleen J; de Boer, Ian H; Flume, Patrick A; Goss, Christopher H; Heltshe, Sonya L; Bhatraju, Pavan K

Pseudomonas infections persisting after CFTR modulators are widespread throughout the lungs and drive lung inflammation

即使使用CFTR调节剂,铜绿假单胞菌感染仍会持续存在于肺部各处,并引发肺部炎症。

Durfey, Samantha L; Kapnadak, Siddhartha G; Pena, Tahuanty; Willmering, Matthew M; Godwin, J David; Teresi, Mary E; Heltshe, Sonya L; Vo, Anh T; Villacreses, Raul A; Aliukonyte, Ieva; Boyken, Linda; Stroik, Mal R; Morgan, Sarah J; Wang, Grace M; Betts, Hannah L; Zhang, Shide; Goss, Christopher H; Clancy, John P; Aitken, Moira L; Steele, Chad; Feder, Alison F; Esther, Charles R Jr; Tiddens, Harm A W M; Woods, Jason C; Stoltz, David A; Singh, Pradeep K

Elexacaftor/tezacaftor/ivacaftor prescription in lung transplant recipients with cystic fibrosis in the US

美国肺移植受者中囊性纤维化患者使用Elexacaftor/tezacaftor/ivacaftor处方

Burdis, Nora C; Bradford, Miranda C; Heltshe, Sonya L; Milinic, Tijana; McElvaney, Oliver J; Lease, Erika D; Goss, Christopher H; Kapnadak, Siddhartha G; Guthrie, Brandon L; Ramos, Kathleen J

Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in 6- to 11-Year-Olds with Cystic Fibrosis: An Observational Study

Elexacaftor/Tezacaftor/Ivacaftor 治疗 6 至 11 岁囊性纤维化患儿的临床疗效:一项观察性研究

Pittman, Jessica E; Morgan, Sarah; McCreary, Morgan; Vu, Phuong T; Jorth, Peter; Heltshe, Sonya; Hoffman, Lucas R; Kelly, Andrea; Sagel, Scott D; Singh, Pradeep K; Solomon, George M; Rosenfeld, Margaret; Ratjen, Felix

The impact of highly effective modulator therapy on sinusitis and dysosmia in young children with cystic fibrosis: a prospective study protocol

高效调节剂疗法对囊性纤维化患儿鼻窦炎和嗅觉障碍的影响:一项前瞻性研究方案

Liu, Christine M; Fischer, Jakob L; Zemanick, Edith T; Woods, Jason C; Markarian, Karolin K; Fain, Sean B; Froh, Deborah; Heltshe, Sonya L; Hoffman, Lucas R; Humphries, Stephen M; Kramer, Elizabeth L; Ode, Katie Larson; Lewis, Michael; Li, Douglas A; Mata, Jaime; Milla, Sarah S; Niedbalski, Peter J; Sawatzky, Benjamin D; Sim, Myung-Shin; Sullivan, Jillian S; Trout, Andrew T; Goss, Christopher H; Taylor-Cousar, Jennifer L; Beswick, Daniel M

Accounting for Inconsistent Use of Covariate Adjustment in Group Sequential Trials

考虑组序贯试验中协变量调整使用不一致的问题

Bannick, Marlena S; Heltshe, Sonya L; Simon, Noah